MAPT and Alzheimer disease: (2019) demonstrated that dysfunction of the IR/IGF‐1R pathway in an AD mouse model can cause a decrease in GSK‐3β phosphorylation, leading to an increase in Tau protein phosphorylation and exacerbating neuronal toxicity, resulting in neuronal apoptosis.